os of healthcare technology investments in four Sprout Capital funds (Sprout Capital IX, L.P., Sprout Capital VIIL L.P., Sprout Capital VIL, L.P. and Sprout Growth II, L.P.), and these are now fully realized (or near fully realized in the case of Sprout Capital IX). The net annual IRR’s on these four funds outperfo